-

Exactech Celebrates a Decade of Relief for Shoulder Patients Suffering from Severe Glenoid Deformity

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, celebrates that ten years ago, the company introduced the Equinoxe® shoulder system’s augmented reverse baseplate and armed surgeons with a new solution for treating patients who suffer from severe glenoid deformity. Dozens of studies over the past ten years have demonstrated significant, clinically meaningful improvements in patients’ pain, range of motion and function when these augmented baseplates are used in reverse total shoulder replacement procedures. For surgeons, the innovative component provided a new and more bone-conserving way to restore rotator cuff muscle tension and minimize scapular notching, while also achieving glenoid fixation.*

As the first company to develop and market this technology, Exactech relied on years of experience in reverse biomechanics to develop augmented baseplates as a component of the Equinoxe® shoulder system.

The Equinoxe augmented baseplates offer surgeons a solution for treating severe asymmetric wear and arthritic deformity of the glenoid. The components are designed to preserve bone through off-axis reaming and avoid medializing the joint line by building up the eroded side rather than reaming to correct the deficiency. The baseplates feature an anatomic shape and an innovative bone cage that provides initial and biologic fixation.*

“Since their introduction 10 years ago, the Equinoxe glenoid augments have truly advanced the standard of care,” said Thomas Wright, MD, University of Florida College of Medicine, Gainesville, Fla. “I started using them in 2011 -- well before the advent of navigation -- because I hated to ream and destroy precious subchondral bone. Preoperative planning software combined with ExactechGPS® navigation has been eye opening; I now find I use an augment 90% of the time. Augments restore the joint line, have very predictable outcomes and, with ExactechGPS navigation, save time. They will always be a main part of my total shoulder arthroplasty practice.”*

Since Exactech’s breakthrough innovation, augmented baseplates have become widely used in the shoulder arthroplasty market.

“We are so proud to have been at the forefront of creating and releasing the augmented baseplates. It’s always remarkable to see the impact revolutionary technologies can have on both the industry and the patients they serve,” said Vice President of Extremities Chris Roche.

Find out more about the Equinoxe augmented reverse baseplates.

*References available on Exactech’s website.

About Exactech

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, VuMedi, YouTube and Instagram.

Contacts

Media Contact
Priscilla Bennett, APR
VP, Corporate Marketing & Communications
(352) 377-1140

Exactech

Details
Headquarters: Gainesville, Fla.
Website: www.exac.com
CEO: Darin Johnson
Employees: 800
Organization: PRI

Release Summary
Exactech Celebrates a Decade of Relief for Shoulder Patients Suffering from Severe Glenoid Deformity
Release Versions

Contacts

Media Contact
Priscilla Bennett, APR
VP, Corporate Marketing & Communications
(352) 377-1140

More News From Exactech

Exactech Announces FDA 510(k) Clearance of the World’s First Surgical Navigation for Total Ankle Replacement

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced its subsidiary, BlueOrtho, has received 510(k) clearance from the Food and Drug Administration for ExactechGPS® Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA). GPS Ankle is a first-of-its-kind technology, which connects the preoperative plan with real-time intraoperative instrument g...

Exactech Publishes New Machine Learning Research That Evaluates Fairness and Accuracy of AI Predictions

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, reports a new study1 that demonstrates its machine learning clinical decision support tool, Predict+™, creates fair and accurate outcomes predictions for shoulder arthroplasty patients of different ethnicity, sex and age. The study, the first of its kind in orthopaedics, has just been published in the Journal of Shoulder and Elbow...

Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today its Active Intelligence® (AI) platform surpassed more than 100,000 total joint replacement surgeries across the globe. “We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exactech CEO Darin Johnson. “As a leader in orthopaedic innov...
Back to Newsroom